SCHEMBL23558264

SCHEMBL23558264

c1ccc(-c2cccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4cccc(-n5c6ccccc6c6ccc(-c7ccc8oc9ccccc9c8c7)cc65)c4)n3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
PLA2G10 O15496 1/20 0.39
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 1/20 0.37
CHEK2 O96017 1/20 0.36
PRKDC P78527 1/20 0.35
HPSE Q9Y251 2/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PGR P06401 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20291338 0.99 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL20290902 0.99 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL20291239 0.99 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL23557840 0.99 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL20291275 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL24303173 0.98 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL16805674 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL24303172 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL20291234 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL23557838 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832515-B2 Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-11-28 US disclosed
US-11832515-B2 Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-11-28 US disclosed
US-20210193932-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210193932-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE OR10J3, ELAVL1, ICOSLG PLA2G2A 3495/4885PLA2G4A 3590/4885PLA2G10 1963/4885
US-11832515-B2 Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device OR10J3, ELAVL1, ICOSLG PLA2G2A 3495/4885PLA2G4A 3590/4885PLA2G10 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.